• EdU Flow Cytometry Assay Kits (Cy5) in Wounds

  2026-08-18

  EdU Flow Cytometry Assay Kits (Cy5) provide direct S-phase DNA synthesis measurement for epithelial wound models. This guide connects copper-catalyzed azide-alkyne cycloaddition (CuAAC) chemistry with the DCPS–cell-cycle findings reported in diabetic foot ulcer research.

• ML385 and NRF2: A Translational Research Playbook

  2026-08-17

  A mechanistic and strategic guide to using ML385 as an NRF2 inhibitor for cancer therapeutic resistance, oxidative stress modulation, and pathway validation beyond conventional product-page claims.

• DiscoveryProbe FDA-approved Drug Library: Stress Screens

  2026-08-17

  Use a clinically annotated compound set to connect proteotoxic-stress phenotypes with actionable signaling hypotheses. This workflow combines scalable primary screening, orthogonal ROS/JNK and CREB assays, and translational follow-up for drug repositioning screening and disease-model discovery.

• RP3-340N1.2, IL-6, and NSCLC Progression

  2026-08-16

  A 2026 BioCell study identifies the lncRNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 mRNA stability in non-small cell lung cancer. Its knockdown enhanced ZC3H12A-mediated IL-6 mRNA degradation, reducing tumor-cell proliferation, migration, and tumor-associated macrophage polarization in cellular and conditioned-medium models.

• LDH Cytotoxicity Assay Kit: Practical Workflow

  2026-08-15

  The LDH Cytotoxicity Assay Kit provides a colorimetric approach to cell cytotoxicity measurement by detecting LDH released into culture medium after membrane damage. It is appropriate for comparative cell damage quantification and viability workflows, but it should not be used alone to identify apoptosis, establish a death mechanism, or replace orthogonal validation.

• Kv6.1 Variants Reshape Kv2.1 Function and Biogenesis

  2026-08-14

  The reference study shows that disease-linked Kv6.1 variants differentially alter Kv2.1 current, inactivation, protein expression, and Kv6.1 phosphorylation. Its key contribution is to connect silent-subunit assembly with both channel gating and post-translational regulation, while highlighting the particularly strong functional and biogenesis effects of Kv6.1[W416C].

• Bobcat339 Workflow for TET-Mediated Methylation

  2026-08-14

  Bobcat339 provides a practical chemical perturbation strategy for testing how TET1/TET2 activity influences DNA methylation, chromatin state, and cell fate. This workflow connects biochemical inhibition with multi-omic and osteogenic assays inspired by a recent senile osteoporosis study, while clearly separating validated product specifications from experiment-specific recommendations.

• From Fluorescent mRNA to Pulmonary Translation

  2026-08-13

  A mechanistic and translational framework for using ARCA Cy5 EGFP mRNA (5-moUTP) to distinguish RNA delivery, intracellular localization, and protein expression across mammalian cell and pulmonary delivery workflows.

• ARCA Cy5 EGFP mRNA (5-moUTP) Workflows

  2026-08-13

  Use ARCA Cy5 EGFP mRNA (5-moUTP) to distinguish cellular mRNA uptake from productive translation in microscopy and flow cytometry. Its covalent Cy5 label, EGFP reporter, ARCA cap, and 5-methoxyuridine modification support practical benchmarking of mRNA delivery systems while reducing dependence on secondary detection.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Readout Logic

  2026-08-12

  EZ Cap Cy5 Firefly Luciferase mRNA enables researchers to separate mRNA transport from productive translation using Cy5 fluorescence and firefly luciferase bioluminescence. This guide presents a decision framework for mRNA delivery and transfection, assay controls, and interpretation beyond conventional reporter workflows.

• Septin4, VHL, and HIF-1α in Cardiac Hypoxia

  2026-08-12

  The reference study identifies HIF-1α as a previously unrecognized Septin4-interacting protein in hypoxia-exposed cardiomyocytes. Its evidence supports a model in which Septin4 strengthens VHL-dependent ubiquitination and degradation of HIF-1α, thereby weakening an endogenous hypoxia-adaptation pathway and aggravating apoptosis.

• Ultrafiltration Purification of Circular RNA

  2026-08-11

  Guillen-Cuevas and colleagues evaluated ultrafiltration as a scalable method for separating protein-encoding circular RNA from linear and nicked RNA species generated during in vitro transcription and self-splicing. By relating membrane molecular-weight cutoff and permeate flux to RNA sieving and critical-flux behavior, the study achieved higher reported purity and yield than size-exclusion HPLC under the tested research-scale conditions.

• FDXR Disease, NRF2 Disruption, and Ferroptosis

  2026-08-11

  The 2025 Cell Death Discovery study identifies ferroptosis as a pathogenic mechanism in FDXR-related mitochondrial disease, linking abnormal iron handling to lipid peroxidation and disruption of the NRF2–SLC7A11 antioxidant axis. Its mouse-model data also suggest that NRF2 activation can mitigate disease-associated pathology, providing a mechanistic basis for therapeutic investigation rather than a disease-specific treatment conclusion.

• Omeprazole A2845: Acid Secretion Workflow Guide

  2026-08-10

  Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, antiulcer activity studies, and related assay development. Its water and ethanol insolubility, DMSO-based handling requirements, and research-only status should be addressed before use in biochemical, cellular, or ex vivo workflows.

• Alda 1: ALDH2 Activator for Cardiac Research

  2026-08-09

  Alda 1 provides a genotype-aware way to study ALDH2 activity, aldehyde detoxification, and cardiomyocyte proliferation. This workflow connects biochemical validation with cardiac ischemia research, pressure-overload models, and carefully bounded exploration of radiation-induced dermatitis mitigation.

7945 records 7/530 page Previous Next First page 上5页 678910 下5页 Last page